BeiGene Signs Up Industry Veterans for Scientific Advisory Board
publication date: Aug 20, 2013
BeiGene, Ltd., a Beijing pharma formed in 2010, announced a Scientific Advisory Board that includes an international list of experts with experience in oncology drugs. The SAB is comprised of: Neal Rosen, MD, PhD; David Schenkein, MD; Charles Sawyers, MD; Xiaodong Wang, PhD; and Steve Young, PhD. BeiGene discovers its own cancer drug candidates and in-licenses molecules that are close to clinical stage for China development. It calls itself a proof-of-concept company. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.